Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jul;4(3):233-7.
doi: 10.2174/157015906778019509.

L-acetylcarnitine: a proposed therapeutic agent for painful peripheral neuropathies

S Chiechio  1 , A Copani, F Nicoletti, R W Gereau 4th
Affiliations

L-acetylcarnitine: a proposed therapeutic agent for painful peripheral neuropathies

S Chiechio et al. Curr Neuropharmacol. 2006 Jul.

Abstract

During the past two decades, many pharmacological strategies have been investigated for the management of painful neuropathies. However, neuropathic pain still remains a clinical challenge. A combination of therapies is often required, but unfortunately in most cases adequate pain relief is not achieved. Recently, attention has been focused on the physiological and pharmacological effects of L-acetylcarnitine in neurological disorders. There are a number of reports indicating that L-acetylcarnitine can be considered as a therapeutic agent in neuropathic disorders including painful peripheral neuropathies. In this review article, we will examine the antinociceptive and the neuroprotective effects of Lacetylcarnitine as tested in clinical studies and in animal models of nerve injury.

Keywords: L-acetylcarnitine; antinociception; neuropathic pain; peripheral neuropathies.

PubMed Disclaimer

References

    1. Angelucci L, Ramacci MT, Taglialatela G, Hulsebosch C, Morgan B, Werrbach-Perez K, Perez-Polo R. Nerve growth factor binding in aged rat central nervous system: effect of acetyl-L-carnitine. J. Neurosci. Res. 1988;20:491–6. - PubMed
    1. Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J. Pain. 2004;5:143–9. - PubMed
    1. Bremer J. Carnitine—metabolism and functions. Physiol. Rev. 1983;63:1420–80. - PubMed
    1. Bremer J. The role of carnitine in intracellular metabolism. J. Clin. Chem. Clin. Biochem. 1990;28:297–301. - PubMed
    1. Brew BJ. The clinical spectrum and pathogenesis of HIV encephalopathy, myelopathy, and peripheral neuropathy. Curr. Opin. Neurol. 1994;7:209–16. - PubMed

LinkOut - more resources